Skip to main content

The Cigna Group

OtherUSverified

Identifiers

website
https://www.thecignagroup.com
org kind
company

What this organization says it wants

We hold no stated position for The Cigna Group. That is our gap, not its silence — we read positions out of federal lobbying filings and state committee witness lists, and this organization has not been matched to either yet.

The positions, and the documents they come from

Every position below links to the record it was read from. We do not store one without a link — a claim you cannot check is the thing this list exists to prevent.

    What it says on the issues

    Statements that name no bill. Each was placed on one of our lines by reading the quote, and kept only where our quiz questions on that line, answered from the same quote, lean the same way. Each counts like one answer to a quiz question.

    • Healthmore policy activity in Health

      “Achieving the intent and vision of mental health parity by improving federal guidance and increasing access to behavioral health providers”

      Published by the organizationOpen the record

    • Health: Insurance Providersmore policy activity in Health: Insurance Providers

      “Preserving patient access and affordability by safeguarding pharmacy benefit and service integration against disruptive restrictions”

      Published by the organizationOpen the record

    • Health: Mental Healthmore policy activity in Health: Mental Health

      “Achieving the intent and vision of mental health parity by improving federal guidance and increasing access to behavioral health providers”

      Published by the organizationOpen the record

    • Domestic Commerce: Copyrights and Patentsless policy activity in Domestic Commerce: Copyrights and Patents

      “Prohibiting anticompetitive tactics and loopholes used by drug manufacturers to delay access to lower-cost generics and biosimilars”

      Published by the organizationOpen the record

    • Domestic Commerce: Copyrights and Patentsless policy activity in Domestic Commerce: Copyrights and Patents

      “Streamlining the U.S. Food and Drug Administration (FDA) approval process for biosimilars, including eliminating the statutory distinction between the approval standard for biosimilars and interchangeable biosimilars”

      Published by the organizationOpen the record

    • Subsidiarity ↔ Centralization (law-making)national standards, preemption

      “Strengthening ERISA preemption to allow employers to offer broad, consistent coverage in the most cost-effective way”

      Published by the organizationOpen the record

    • Middlemen owning pharmacies (PBMs)leave it to the market

      “Supporting access to higher-value care by ensuring health plans and pharmacy benefit managers (PBMs) retain their ability to use formularies and utilization management tools”

      Published by the organizationOpen the record

    • Middlemen owning pharmacies (PBMs)leave it to the market

      “Preserving patient access and affordability by safeguarding pharmacy benefit and service integration against disruptive restrictions”

      Published by the organizationOpen the record

    9 more readings were held back because the quiz questions on that line did not agree with them, or could not be answered from the quote.

    What we don't have on this organization

    • No politicians linked

      We have no contribution from this organization to any candidate on file yet. The contribution walk is still running, so this may be a gap in our ingestion rather than in its giving.

    • No committee totals

      This committee’s own receipts and disbursements — its totals as filed — are not ingested. What we hold about its money is the contributions we have matched to named candidates.